Olympus' modified duodenoscope receives FDA approval, EndoChoice stock lowered to "sell" & more — 4 GI/endoscopy company key notes

Here are four recent news updates on gastroenterology and endoscopy companies.

MarketBeat shows that Zacks lowered EndoChoice Holdings stock from a "hold" rating to a "sell" rating.

Apollo Medical appointed Thomas Lam, MD, to its board of directors.

Olympus' TJF-Q180V duodenoscope that includes modifications to the device design and labeling has received FDA 510(k) clearance.

Ardelyx, a gastroenterology and cardio-renal company, named Paul Korner, MD, MBA, executive vice president and CMO.